These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16930633)

  • 1. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
    Dickson L; Aramori I; McCulloch J; Sharkey J; Finlayson K
    Neuropharmacology; 2006 Nov; 51(6):1086-98. PubMed ID: 16930633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPAC and PAC receptors: From ligands to function.
    Dickson L; Finlayson K
    Pharmacol Ther; 2009 Mar; 121(3):294-316. PubMed ID: 19109992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways.
    Dickson L; Aramori I; Sharkey J; Finlayson K
    Ann N Y Acad Sci; 2006 Jul; 1070():239-42. PubMed ID: 16888173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
    Eggenberger M; Born W; Zimmermann U; Lerner EA; Fischer JA; Muff R
    Neuropeptides; 1999 Apr; 33(2):107-14. PubMed ID: 10657479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
    Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
    Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
    Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
    Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a small molecule antagonist of human VPAC(2) receptor.
    Chu A; Caldwell JS; Chen YA
    Mol Pharmacol; 2010 Jan; 77(1):95-101. PubMed ID: 19854890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery.
    Boni LJ; Ploug KB; Olesen J; Jansen-Olesen I; Gupta S
    Cephalalgia; 2009 Aug; 29(8):837-47. PubMed ID: 19220306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity.
    Ito T; Igarashi H; Pradhan TK; Hou W; Mantey SA; Taylor JE; Murphy WA; Coy DH; Jensen RT
    Peptides; 2001 Jul; 22(7):1139-51. PubMed ID: 11445245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
    Juarranz MG; Bodega G; Prieto JC; Guijarro LG
    Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.